BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19766247)

  • 1. Platonin improves survival of skin allografts.
    Cheng SP; Lee JJ; Chi CW; Chang KM; Chen YJ
    J Surg Res; 2010 Nov; 164(1):146-54. PubMed ID: 19766247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platonin attenuates LPS-induced CAT-2 and CAT-2B induction in stimulated murine macrophages.
    Chen CC; Lee JJ; Tsai PS; Lu YT; Huang CL; Huang CJ
    Acta Anaesthesiol Scand; 2006 May; 50(5):604-12. PubMed ID: 16643232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of an ethyl acetate extract from Urtica dentata Hand on skin allograft rejection.
    Xiang M; Hou WR; Xie SN; Zhang WD; Wang X
    J Ethnopharmacol; 2009 Oct; 126(1):57-63. PubMed ID: 19698774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercapnic acidosis prolongs survival of skin allografts.
    Tzeng YS; Wu SY; Peng YJ; Cheng CP; Tang SE; Huang KL; Chu SJ
    J Surg Res; 2015 May; 195(1):351-9. PubMed ID: 25577144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
    Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
    Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production.
    Lee SJ; Namkoong S; Ha KS; Nam WD; Kwon YG; Lee H; Yoon EY; Chang DJ; Kim SO; Kim YM
    Exp Mol Med; 2007 Apr; 39(2):230-8. PubMed ID: 17464185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
    Finn PW; He H; Ma C; Mueller T; Stone JR; Liou HC; Boothby MR; Perkins DL
    J Leukoc Biol; 2002 Nov; 72(5):1054-62. PubMed ID: 12429729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.
    Holán V; Pindjáková J; Krulová M; Neuwirth A; Fric J; Zajícová A
    Transplantation; 2006 Jun; 81(12):1708-15. PubMed ID: 16794538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cytokine functions in graft rejection by gene expression profiles.
    Liang Y; Christopher K; DeFina R; Cidado J; He H; Haley KJ; Finn PW; Perkins DL
    Transplantation; 2003 Dec; 76(12):1749-58. PubMed ID: 14688527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase inhibitors prolonged the survival of skin xenografts through selective down-regulation of pro-inflammatory cytokine and CC-chemokine expressions.
    Kim JY; Kim D; Lee EM; Choi I; Park CG; Kim KS; Ha J; Kim SJ; Yang J; Kim YS; Han JS; Kim S; Lee JS; Ahn C
    Transpl Immunol; 2003; 12(1):63-72. PubMed ID: 14551033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity.
    Kovalchin JT; Mendonca C; Wagh MS; Wang R; Chandawarkar RY
    Transpl Immunol; 2006 Jan; 15(3):179-85. PubMed ID: 16431284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
    Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
    Thai NL; Fu F; Qian S; Sun H; Gao L; Wang SC; Demetris AJ; Woo J; Thomson AW; Duquesnoy RJ
    Transplantation; 1995 Jan; 59(2):274-81. PubMed ID: 7530874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
    Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
    J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.